Search Results (17)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| 2019 Drug Metabolism Gordon Research Conference Guiding Drug Development Using Translational ADME Science | Grant |
Why?
|
| Heartland Institute for Clinical and Translational Research | Grant |
Why?
|
| Cancer Center Support Grant | Grant |
Why?
|
| Ontogeny and Genetics of NSAID Dose-Exposure Relationship in Preterm Infants | Grant |
Why?
|
| Nrf2 as a Master Regulator in Liver Disease Prevention and Therapy | Grant |
Why?
|
| Frontiers: University of Kansas Clinical and Translational Science Institute | Grant |
Why?
|
| Pharmacogenetics in pediatrics. Implications for practice. | Academic Article |
Why?
|
| Harnessing anti-cancer immunity to vaccinate against treatment failure and relapse | Grant |
Why?
|
| Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals. | Academic Article |
Why?
|
| Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. | Academic Article |
Why?
|
| Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants. | Academic Article |
Why?
|
| Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life. | Academic Article |
Why?
|
| Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development. | Academic Article |
Why?
|
| Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group. | Academic Article |
Why?
|
| Developmental pharmacokinetics and pharmacodynamics of nizatidine. | Academic Article |
Why?
|